Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Fish and Richardson
Harvard Business School
Chubb
Teva
Queensland Health
Dow
UBS
Cantor Fitzgerald

Generated: May 27, 2018

DrugPatentWatch Database Preview

Cefonicid sodium - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for cefonicid sodium and what is the scope of cefonicid sodium freedom to operate?

Cefonicid sodium
is the generic ingredient in one branded drug marketed by Glaxosmithkline and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

Summary for cefonicid sodium
US Patents:0
Tradenames:1
Applicants:1
NDAs:2
Bulk Api Vendors: 36
Clinical Trials: 2,428
Patent Applications: 4,209
DailyMed Link:cefonicid sodium at DailyMed
Medical Subject Heading (MeSH) Categories for cefonicid sodium
Synonyms for cefonicid sodium
(6R,7R)-7-((R)-2-Hydroxy-2-phenylacetamido)-8-oxo-3-(1-sulfomethyl-1H-tetrazol-5-yl)thiomethyl)-5-thia-1-azabicyclo(4.2.0)-2-en-2-carbonsaeure mononatrium-salz
(6R,7R)-7-((R)-Mandelamido)-8-oxo-3-(((1-(sulfomethyl)-1-H-tetrazol-5-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, disodium salt
(6R,7R)-7-((R)-Mandelamido)-8-oxo-3-(((1-(sulfomethyl)-1H-tetrazol-5-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, S-sodium salt
(6R,7R)-7-[(2R)-2-hydroxy-2-phenylacetamido]-8-oxo-3-({[1-(sulfomethyl)-1H-1,2,3,4-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2R)-2-hydroxy-1-oxo-2-phenylethyl]amino]-8-oxo-3-[[[1-(sulfomethyl)-5-tetrazolyl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2R)-2-Hydroxy-2-phenylacetyl]amino]-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Disodium Salt
(6R,7R)-7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-8-oxo-3-[[1-(sulfomethyl)tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]thio}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-8-oxidanylidene-7-[[(2R)-2-oxidanyl-2-phenyl-ethanoyl]amino]-3-[[1-(sulfomethyl)-1,2,3,4-tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
[5-[[(6R,7R)-2-carboxy-7-[[(2R)-2-hydroxy-2-phenyl-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methylsulfanyl]tetrazol-1-yl]methanesulfonate; sodium
190181-58-9
270C584
270C788
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino)-8-oxo-3-(((1-(sulfomethl)-1H-tetrazol-5-yl)thio)methyl)-, monosodium salt, (6R-(6 alpha, 7 beta (R*)))
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino)-8-oxo-3-(((1-(sulfomethyl)-1H-tetrazol-5-yl)thio)methyl)-, monosodium salt, (6R-(6alpha,7beta(R*)))-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino)-8-oxo-3-(((1-(sulfomethyl)-1H-tetrazol-5-yl)thio)methyl)disodium salt, (6R-(6alpha,7beta(R*)))
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino)-8-oxo-3-(((1-(sulfomethyl)-1H-tetrazol-5-yl)thio)methyl)disodium salt, (6R-(6alpha,7beta(R*)))-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino)-8-oxo-3-(((1-sulfomethyl)-1H-tetrazol-5-yl)thio)methyl)-, (6R-(6-alpha,7-beta(R*)))-
61270-58-4
61270-58-4 (Parent)
61270-78-8
61270-78-8 (di-hydrochloride salt)
6532B86WFG
6beta-[(2R)-2-hydroxy-2-phenylacetamido]-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)ceph-3-em-4-carboxylic acid
71420-79-6
A833135
AC1L2A79
AC1L2A7C
AC1Q6LOE
AKOS015896359
AN-39345
BIDD:GT0667
BRN 1066181
C-23163
C-23288
C-2478
C06882
C08105
C18H16N6Na2O8S3
C18H16N6O8S3.2Na
CAS-61270-78-8
CC-25571
CC-25572
Cefodie
CEFONICID
Cefonicid (INN)
Cefonicid (sodium)
cefonicid disodium
Cefonicid disodium salt
Cefonicid monosodium
Cefonicid monosodium (USAN)
Cefonicid monosodium [USAN]
Cefonicid sodium (USP)
Cefonicid sodium [USAN:USP]
Cefonicid sodium [USAN]
Cefonicid sodium salt
Cefonicido
Cefonicidum
CHEBI:3491
CHEBI:3492
CHEMBL1201005
CHEMBL1601
CS-5306
CTK2H9545
D00912
D03426
D07644
DB01328
Disodium (6R,7R)-7-[[(2R)-2-hydroxy-2-phenyl-acetyl]amino]-8-oxo-3-[[1-(sulfonatomethyl)tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
disodium (6R,7R)-7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-8-oxo-3-[[1-(sulfonatomethyl)tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
DSSTox_CID_26642
DSSTox_GSID_46642
DSSTox_RID_81788
DTXSID0046642
DTXSID7022758
DYAIAHUQIPBDIP-AXAPSJFSSA-N
F74MFL78A1
FT-0603041
HE362088
HY-B1300
I06-1924
LS-176162
LS-187318
MFCD00941437
MolPort-020-003-975
Monocef (TN)
Monocid
Monocid (TN)
Monocidur
Mopnocid
NCGC00167458-01
QD9G66C5UF
SCHEMBL41895
SCHEMBL60350
SCHEMBL8425120
SK&F D-75073-Z
SK&F D-75073-Z2
SK&F-D-75073-Z2
SKF 75073
ST51053293
Tox21_112462
UNII-6532B86WFG
UNII-F74MFL78A1
UNII-QD9G66C5UF
ZINC3830428

US Patents and Regulatory Information for cefonicid sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline MONOCID cefonicid sodium INJECTABLE;INJECTION 050579-003 May 23, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline MONOCID cefonicid sodium INJECTABLE;INJECTION 050579-002 May 23, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline MONOCID cefonicid sodium INJECTABLE;INJECTION 050579-001 May 23, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline MONOCID cefonicid sodium INJECTABLE;INJECTION 063295-001 Jul 26, 1993 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Colorcon
McKinsey
Mallinckrodt
Chubb
Fish and Richardson
Dow
Federal Trade Commission
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.